SHARDACROP Q4 FY26 Results & Earnings Analysis
Sentiment: Good (Confidence: high)
Earnings Summary
Sharda Cropchem reported its best-ever financial performance in FY26 with 22% revenue growth, 600 bps gross margin expansion, 69% EBITDA growth, and 124% PAT growth. The company remains debt-free with INR 702 crores in cash. FY27 guidance is slightly cautious at 10-15% revenue growth and 18-20% EBITDA margins, with volume growth expected around 15%. The registration moat (3,011 registrations, 1,004 in pipeline) and diversified presence in 70+ countries provide competitive advantages. Key risks include geopolitical uncertainties, forex volatility, and regulatory delays in registrations. ,,
Management Tone
- Prepared Remarks: Good — Management described FY26 as 'the best year in Sharda Cropchem's history' and expects growth momentum to continue, with a confident tone on the business model and registration moat.
- Q&A Session: Neutral — Analysts pressed on the downward revision of revenue guidance (from prior 15-20% to 10-15%), margin sustainability, and forex impacts. Management responses were cautious and included non-specific 'impressions' rather than firm commitments. ,,
Revenue Growth Drivers
- Volume growth of 13.4% in FY26 driven by Europe and LATAM
- Forex impact of +10.3% in FY26
- Price/product mix impact of -1.8% in FY26
Growth vs Margin Focus
Management guided for 10-15% revenue growth while maintaining 18-20% EBITDA margins and ~35% gross margins, indicating balanced focus. ,
About Sharda Cropchem Limited
Sharda Cropchem Limited (SHARDACROP) is listed on NSE. View the latest earnings analysis, AI-powered insights, and sentiment data on StockMirror.